PGA
NVO

Premia Global Advisors’s Novo Nordisk NVO Stock Holding History

Premia Global Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,078
Closed -$28K – 276
2019
Q1 		$28K Buy
+1,078
New +$26.5K 0.03% 262
2018
Q2 		– Sell
-890
Closed -$21K – 317
2018
Q1 		$21K Buy
890
+188
+27% +$4.94K 0.02% 284
2017
Q4 		$18K Buy
+702
New +$17.9K 0.02% 305

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Premia Global Advisors's NVO Position: Q2 2019 in Review

Premia Global Advisors sold out of Novo Nordisk (NVO) in Q2 2019, closing a stake of 1,078 shares — an estimated $28K sold.

Premia Global Advisors first reported a position in NVO in Q4 2017 and held it in 3 quarters. The position peaked at $28K in Q1 2019. 559 funds tracked by Wall St. Rank hold NVO as of Q2 2019.

  • Premia Global Advisors reported no remaining Novo Nordisk position as of Q2 2019 after selling out during the quarter.
  • Premia Global Advisors sold 1,078 Novo Nordisk shares in Q2 2019, an estimated $28K.
  • Premia Global Advisors first reported a position in Novo Nordisk in Q4 2017 and held it in 3 quarters.
  • Premia Global Advisors's Novo Nordisk position peaked at $28K in Q1 2019.
  • 559 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2019.

Based on Premia Global Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.